Oncology

Cargo Therapeutics

Clinical-stage company developing a new generation of adoptive cell therapies for cancers, with a focus on addressing primary mechanisms of resistance to CAR-T therapies.

Red Tree Participation
Co-investor in seed round, co-led bridge round, co-investor in Series A

Red Tree Board Member

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Red Tree Participation
Co-investor in seed round, co-led bridge round, co-investor in Series A

Cargo Therapeutics

Oncology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Affiliated with Red Tree SAB Member

Red Tree Participation
Co-investor in seed round, co-led bridge round, co-investor in Series A